TDACW
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Financial - Conglomerates · US
$1.60
+10.34%Price chart
Aug 14Aug 19Aug 24Aug 27Sep 1Sep 8Sep 11Sep 17
Key dataSep 17, 2026
Open$1.60
From 52W high−25.58%
Volume102.00
Market cap$27.60M
P/E (TTM)6.2x
P/S (TTM)—
Div yield—
Key dataSep 17, 2026
Open
$1.60
From 52W high
−25.58%
Volume
102.00
Market cap
$27.60M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−21.7x
P/E (TTM)
6.2x
RSI (14)
46.9
MomentumView details →
1D Return
+10.34%
YTD Return
+416.13%
Similar companies
Jones Ventures INTL Acquisition1 Corp RightsJONERColumbus Circle Capital Corp IICMIIWCartesian Growth Corporation IIIFACWWAustralian Oilseeds Holdings Limited WarrantCOOTWBRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series B Cumulative Perpetual Preferred StockRILYLBRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series A Cumulative Perpetual Preferred StockRILYPFind similar companies →
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.54d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.76d ago